D64.81

Clinical Causes: Chemotherapy drugs targeting rapidly dividing cancer cells also affect healthy bone marrow cells responsible for red blood cell production. Certain chemotherapy agents are more likely to cause anemia due to their mechanism of action. Cumulative effects of multiple chemotherapy cycles can impair red blood cell synthesis over time. Pre-existing anemia or bone marrow suppression from other treatments may increase risk. Nutritional deficiencies that impair red blood cell production, such as iron, vitamin B12, or folate deficiencies, may exacerbate chemotherapy-induced anemia.

Key Symptoms: Fatigue and generalized tiredness Weakness and decreased exercise tolerance Shortness of breath, especially during activity Pale skin or pallor Dizziness or lightheadedness Headache Heart palpitations

Diagnosis Path: Diagnosis typically involves blood tests to measure hemoglobin and hematocrit levels, which are often lowered in anemia. A complete blood count (CBC) helps assess the severity of anemia. Additional tests may include reticulocyte count to evaluate bone marrow response, and iron, vitamin B12, and folate levels to identify other contributing factors. The patient's medical history, including chemotherapy regimen details, is also considered to determine if anemia is related to treatment. Regular monitoring during chemotherapy helps detect anemia early for prompt management.

Treatment Protocols: Management of chemotherapy-induced anemia aims to alleviate symptoms and support the patient's overall well-being. Treatment options include: - **Blood transfusions**: Providing red blood cells directly to relieve severe anemia symptoms. - **Erythropoiesis-stimulating agents (ESAs)**: Medications that stimulate red blood cell production, used under careful medical supervision due to potential risks. - **Adjustments to chemotherapy**: Modifying the treatment plan may be considered in some cases. - **Nutritional support**: Ensuring adequate intake of iron, vitamin B12, and folate if deficiencies are present. - **Supportive care**: Managing fatigue through rest, energy conservation strategies, and physical activity tailored to the patient's capacity. Close communication with the healthcare team is vital to balance effective cancer treatment with managing side effects like anemia. Individualized treatment plans consider the patient's overall health, cancer type, and response to therapy.